Depression Research and TreatmentVolume 2011 (2011), Article ID 126895, 9 pagesdoi:10.1155/2011/126895

Research Article

Clinical and Physiological Correlates of Irritability in Depression: Results from the Netherlands Study of Depression and Anxiety

Floor E. A. Verhoeven,¹ Linda Booij,2,3 Nic J. A. Van der Wee,⁴ Brenda W. H. J. Penninx,4,5,6 and A. J. Willem Van der Does1,4

¹Faculty of Social and Behavioural Sciences, Institute of Psychology, Leiden University, Wassenaarseweg 52, 2333 AK Leiden, The Netherlands²Sainte-Justine Hospital Research Center, 3175 Chemin de la Côte Sainte-Catherine, Montreal, QC, Canada, H3T 1C5³Department of Psychiatry, University of Montreal, 2900 Boulevard Édouard-Montpetit, Montreal, QC, Canada, H3T 1J4⁴Department of Psychiatry, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands⁵Department of Psychiatry, VU University Medical Center, A.J. Ernststraat 1187 , 1081 HL Amsterdam, The Netherlands⁶Department of Psychiatry, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands

Received 11 February 2011; Revised 18 August 2011; Accepted 18 August 2011

Academic Editor: H. Grunze

Copyright © 2011 Floor E. A. Verhoeven et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objective. Irritable and nonirritable depressed patients differ on demographic and clinical characteristics. We investigated whether this extends to psychological and physiological measures. Method. We compared irritable and nonirritable unipolar depressed patients on symptomatology, personality, and (psycho)physiological measures (cortisol, cholesterol, and heart rate variability). Symptomatology was reassessed after one year, and we also compared depressed patients who were irritable or non-irritable at both time points (Irr++ versus Irr−−). Results. Almost half (46%; ) of the sample was classified as irritable. These patients scored higher on depression severity, anxiety, hypomanic symptoms, and psychological variables. No differences were observed on physiological markers after correction for depression severity. The same pattern was found when comparing Irr++ and Irr−− groups. Conclusion. Irritable and non-irritable depressed patients differ on clinical and psychological variables, but not on the currently investigated physiological markers. The clinical relevance of the distinction and the significance of the hypomanic symptoms remain to be demonstrated.

1. Introduction

Not all symptoms that are prevalent in major depression are part of its diagnostic criteria [1]. For instance, most depressed patients experience significant levels of anxiety. Irritability is also reported by many. In children, irritability is the most common symptom of depression [2] and is one of the diagnostic criteria. Two recent studies have examined the clinical significance of irritability in depression in adults. In a community sample of depressed patients, approximately half of the 955 patients with lifetime unipolar depression were also irritable during their worst episode [3], as measured with one item of the Composite International Diagnostic Interview. Depressed patients scoring positive on irritability had a younger age of onset and higher rates of comorbid attention-deficit/hyperactivity disorder, oppositional-defiant disorder, intermittent explosive disorder, dysthymia and anxiety disorders [3]. A second study [4] compared depressed patients with and without irritability based on the irritability item of a standardized symptom interview. Irritable depressed patients (; 46%) reported more anxiety, loneliness and annoyance by daily hassles, and more prior suicide attempts than nonirritable depressed patients.

Previous research by the same group focused on a depression subtype characterized by the presence of anger attacks, in other words by disturbances in the regulation of irritability [5–7]. Around 40% of depressed outpatients had one or more anger attacks during the past month [8, 9]. In comparison with depressed patients without anger attacks, these patients had higher levels of hostility, anxiety, somatization [9], higher cholesterol levels [10], more axis II psychopathology [11], increased risk of cardiac dysfunction [12], and a younger age of depression onset [13]. Depressed patients with anger attacks also showed a blunted response to the serotonin (5-HT) agonist fenfluramine [14]. Compared to healthy controls, depressed patients with anger attacks showed differential activation of orbitofrontal–limbic circuits following an anger induction task [15].

It has been suggested that irritability may also be a feature of unrecognized bipolar (spectrum) disorder [16–18]. It has not been investigated yet to what extent irritability during a depressive episode predicts the development of bipolar disorder. However, other features of bipolar disorder, such as early age of onset, suicidality, family history, greater episode recurrence, and atypical depression were not found to be more common in the irritable depressed [4].

The present study had two aims. The first aim was to investigate whether the psychological and biological profile that has been found for depressed patients with anger attacks also applies to depressed patients with irritability. We compared outpatients with irritable and nonirritable unipolar depression on demographic, clinical, psychological, and biological markers that had previously been associated with impulsivity, aggression, or anger attacks. These markers include personality, cognitive reactivity, heart rate variability [12], cholesterol [10], and cortisol [19]. We hypothesized that depressed patients reporting irritability would score higher on anxiety and suicidality, lower on agreeableness, and higher on aggression reactivity. We also expected that irritable depression would be associated with lower heart rate variability, lower cholesterol concentrations, and higher levels of cortisol, particularly the cortisol awakening rise. The second aim was to investigate the association of irritability in depression with features of (hypo-)mania. For this, we measured (hypo-)manic symptoms in the same patients.

2. Methods

2.1. Participants

Participants were selected from the Netherlands Study of Depression and Anxiety (NESDA). This cohort study follows 2,981 adult participants over the course of 8 years [20]. NESDA respondents were recruited from the community and through primary and secondary care facilities. The total NESDA sample contains 2,329 individuals with a lifetime diagnosis of depression, dysthymia and/or an anxiety disorder, and 652 healthy participants. Participants with a diagnosis of bipolar disorder, a psychotic disorder, obsessive compulsive disorder, or severe addiction disorder are excluded from NESDA. For the present study, we selected the 913 participants who met the criteria for major depression, minor depression, or dysthymia during the month prior to study admission.

2.2. Instruments

2.2.1. Diagnoses

Current and past DSM-IV diagnoses of mood disorders, anxiety disorders, and alcohol abuse and dependency were assessed with the Composite International Diagnostic Interview (CIDI) [21]. The interviews were conducted and scored by trained and supervised clinical research staff. Psychotic disorders and addictions were assessed in an open interview and checked in the medical records. Severity of alcohol dependence and abuse was assessed with the Audit questionnaire [22].

2.2.2. Symptomatology

Severity of depression during the past week was defined as the total score on the Inventory of Depressive Symptomatology (IDS-SR) [23], excluding the irritability item. Anxiety symptoms were assessed with the Beck Anxiety Index (BAI) [24]. The BAI measures the somatic and cognitive aspects of anxiety during the past week (e.g., “numbness or tingling” and “fear of the worst happening”). It contains 21 items, scored on a four-point scale. The symptoms of bipolar disorder were assessed with the Mood Disorder Questionnaire (MDQ) [25], which contains 13 items derived from DSM-IV criteria and clinical experience (e.g., “you were so irritable that you shouted at people or started fights or arguments” and “you felt more self-confident than usual”).

2.2.3. Irritability

Irritability status was determined using one item from the Inventory of Depressive Symptomatology—Self-Report (IDS-SR) [23]. This item asks whether the participant has been “feeling irritable during the past seven days”. The answers are scored on a four-point scale with descriptors “not feeling irritable” (1), “feeling irritable less than half the time” (2), “feeling irritable more than half the time” (3), or “feeling extremely irritable nearly all of the time” (4). The sample was split into low (scoring 1 or 2) (Irr−) and high irritable groups (scoring 3 or 4) (Irr+). The validity of this criterion has been shown previously in other cohorts [3, 4], but since the IDS measures past week severity only, irritability was reassessed at a one-year followup. This allowed us to create somewhat more extreme subgroups of depressed patients who were irritable both at baseline and at one-year followup (Irr++) and patients who were nonirritable on both assessments (Irr−−).

2.2.4. Suicidality

Previous suicide attempts were assessed with the Beck scale for suicide ideation [26].

2.2.5. Psychological Variables

Cognitive vulnerability to depression was measured with the Leiden Index of Depression Sensitivity—Revised (LEIDS-R) [27, 28]. The LEIDS-R, a 34-item self-report scale, measures cognitive reactivity to sad mood on the following subscales: hopelessness/suicidality, acceptance/coping, aggression, control/perfectionism, risk aversion and rumination. Personality traits were assessed with the short form of the NEO Five Factor Inventory (NEO-FFI) [29].

2.3. Physiological Variables

2.3.1. Cortisol Awakening Rise

Cortisol awakening response was used to investigate HPA-axis function [30]. During the baseline assessment, patients were instructed to collect four cortisol samples on a regular (working) day shortly after the interview. Samples were taken at awakening and at 30, 45, and 60 minutes after the first sample, after which they were returned by mail after collection. Median time between the interview and saliva sampling was 9.0 days (25th–27th percentile, 4–22 days). Outcome measures were the area under the curve with respect to the ground (AUCg) and the area under the curve with respect to the increase (AUCi) [31, 32].

2.3.2. Cholesterol

Total cholesterol, low-density lipoprotein (LDL) and high-density lipoprotein (HDL), and cholesterol levels (both measures of serum cholesterol) were assayed from a blood sample taken after an overnight fast [33].

2.3.3. Heart Rate Variability (HRV)

Heart rate variability (HRV) was assessed using a VU-AMS monitoring system [34] which was worn during most of the baseline measurement (average registration 99.9 minutes). The various phases of the session (resting baseline, interviews, and a cognitive task) were marked using an event button. Mean heart rate, standard deviation of the interbeat intervals (SDNN), and the different measures of respiratory sinus arrhythmia (RSA) were calculated from the interbeat interval (IBI) time series and respiration signal [34–36]. For the current study, we investigated SDNN and RSA measured in (supine) rest condition (during which no interview was conducted) and during performance of a cognitive test (test condition) [37].

2.4. Data Screening

Data were checked for missings and outliers, normality of distributions, and homogeneity of variances. 145 of the 913 participants did not return their questionnaire package resulting in 145 missings on all variables of the LEIDS-R. On the age of onset variable, 162 participants had missing values. In about half of the other variables, a low number of missing values (<20) were replaced with the series mean of their subgroup (Irr+/Irr−) according to Tabachnik and Fidell [38]. The dataset was complete for the other variables. After removal of outliers (scores higher or lower than 2 standard deviations from the mean) [32], cortisol data were normally distributed. There were no statistical outliers (based on Cook’s distances and studentized residuals) on any of the other variables.

2.5. Statistical Analyses

Group differences (Irr+ versus Irr−) were investigated by general linear models (GLMs). This was done in two steps. First, data were explored by using separate univariate GLMs with group (Irr+/Irr−) as the between subjects factor. Alpha was set at 0.05, however all outcome variables significant at the level in these univariate analyses were entered in a multivariate GLM to take into account correlations among the dependent variables. Covariates were included in the univariate and multivariate analyses in order to reduce error variance [39]. The choice of covariates in each of the analyses was based on literature review and results of previous studies conducted in NESDA [37, 40]. Age, gender, and current depression symptoms were included as covariates in the GLMs for the LEIDS-R and NEO-FFI subscale and total scores. For the cortisol measures, we entered physical activity, smoking, cardiovascular disease, whether the participant was working on the day of data collection and hours of daylight in the month of data collection as covariates. In the HRV and cholesterol analyses, covariates were age, gender, depression severity, alcohol dependence and abuse, use of antidepressants, and heart medication. Participants were classified as nonsmoker, former smoker, smoker, or heavy smoker (>20 tobacco consumptions a day), and similar categories were made for alcohol use: nondrinker, mild drinker (<7 units/week), moderate drinker (7–14 u/wk), and heavy drinker (≥15 u/wk). Energy spent on physical activity per week was measured with the International Physical Activity Questionnaire [41]. Chi-square statistics were used in case of categorical variables. Logistic regression analysis was used to control for potential confounders in relationships involving categorical variables.

3. Results

3.1. Demographic and Clinical Characteristics

Univariate analyses showed that the irritable depressed group was significantly older than the nonirritable depressed group (; ). There was no significant difference in the distribution of males and females over the two groups (; ). Participants in the Irr+ group had been recruited from specialized mental health institutions more often than participants in the Irr− group (; ).

Table 1 shows that the Irr+ group also had notably higher scores on severity of depression (IDS total minus Item 6; Irritability) (; ) than the Irr− group. This pattern was present at each recruitment site, with 9 points difference between Irr+ and Irr− in primary care (; ) and specialized mental health care (; ) and 13 points difference in the general population (; ). Irr+ participants also had higher anxiety (BAI total) symptoms (; ) and more lifetime anxiety disorders (; ). Current GAD (; ), panic disorder (; ), and social anxiety disorder (; ) were also more prevalent in the Irr+ group.

Table 1: Demographic and clinical characteristics of low and high irritable depressed patients: univariate results.

Low irritable ()
High irritable ()

Demographic features

Age (mean ± SD)
43.4 ± 12.3
40.7 ± 11.7
*

Sex (% female)
65.9
65.7
OR = 0.99 (CI: 0.75–0.30)

Recruited from:

    Specialized mental health care (%)
45.2
58.6
OR = 1.71** (CI: 1.32–2.23)

    Community + primary care (%)
54.8
41.4

Clinical features

Age of onset (mean ± SD)‡
28.6 ± 13.1
26.6 ± 12.2
*

Smoking (% yes)
43.4
48.1
OR = 1.21 (CI: 0.93–1.57)

Alcohol (% recent abuse and/or dependence)
8.5
8.1
OR = 0.95 (CI: 0.59–1.52)

Comorbid anxiety (CIDI diagnosis%)
73.6
80.2
OR = 1.45* (CI: 1.06–1.99)

    GAD (%)
24.9
36.7
OR = 1.74** (CI: 1.31–2.31)

    Panic disorder (%)
22.7
37.1
OR = 2.01** (CI: 1.51–2.68)

    Social phobia (%)
26.2
39.0
OR = 1.82** (CI: 1.37–2.39)

IDS total score (mean ± SD)a
27.8 ± 10.1
37.7 ± 9.5
**

First degree family history with depression (%)
84.4
85.0
OR = 1.05 (CI: 0.73–1.51)

Beck Anxiety Inventory (mean ± SD)
15.8 ± 9.4
23.8 ± 11.4
**

Suicidality (% ≥1 attempt during lifetime)
17.4
25.2
OR = 1.60* (CI: 1.16–2.20)

Low irritable ()
High irritable ()

MDQ (% yes)

    Elated mood
28.8
32.0
OR = 1.20 (CI: 0.88–1.64)

    Increased self-confidence
39.4
39.9
OR = 1.02 (CI: 0.76–1.37)

    Less sleep needed
42.0
44.0
OR = 1.09 (CI: 0.81–1.45)

    More and/or faster speech
50.7
57.5
OR = 1.34 (CI: 1.01–1.79)*

    Racing thoughts
75.6
84.5
OR = 1.84 (CI: 1.27–2.68)*

    Concentration problems
74.6
85.3
OR = 2.06 (CI: 1.41–3.00)**

    More energy
44.6
45.7
OR = 1.06 (CI: 0.80–1.42)

    Increased activity
49.8
48.7
OR = 0.98 (CI: 0.73–1.30)

    Heightened sociability
23.9
28.4
OR = 1.27 (CI: 0.92–1.76)

    Increased libido
29.1
32.8
OR = 1.20 (CI: 0.88–1.64)

    Risk taking
25.8
32.8
OR = 1.41 (CI: 1.03–1.93)

    Financial risk taking
13.4
18.2
OR = 1.45 (CI: 0.98–2.14)

bNEO FFI (mean ± SD)

    Neuroticism
40.6 ± 6.6
45.2 ± 6.1
*

    Extraversion
33.9 ± 6.7
31.1 ± 6.6

    Openness
31.1 ± 5.0
30.1 ± 6.0

    Agreeableness
43.5 ± 5.1
41.0 ± 5.6
**

    Conscientiousness
35.3 ± 6.2
34.3 ± 6.3

Low irritable ()
High irritable ()

bLEIDS-R (mean ± SD)

    Hopelessness
6.8 ± 4.8
9.2 ± 5.2

    Acceptance
1.9 ± 2.2
2.0 ± 2.6

    Aggression
5.0 ± 4.3
8.6 ± 5.1
**

    Control
6.4 ± 3.8
7.3 ± 4.1

    Risk aversion
10.6 ± 4.5
12.0 ± 4.6

    Rumination
11.4 ± 4.7
13.5 ± 4.2

    Total score
42.2 ± 17.5
52.7 ± 17.3

*.05 < P >.001.

.

(low irritable. , high irritable, ).

aIDS-SR total score minus the score on the irritability item.

bControlled for current symptoms (IDS-total minus item 6), gender, and age.

More patients in the Irr+ group had previously attempted suicide than patients in the Irr− group (25% versus 17%; ; ). However, an additional logistic regression analysis showed that the association between irritability and suicidality was no longer statistically significant after controlling for depression severity. Patients in the Irr+ group scored higher on three mania items of the MDQ: talkativeness (; ), racing thoughts (; ), and distractibility (; ).

3.2. Cognitive Vulnerability

The Irr+ group scored higher on all subscales of the LEIDS-R, with exception of the acceptance subscale. The Irr+ group also had a significantly higher LEIDS-R total score (; ). After adding age, gender, and IDS total score as covariates, only the difference between the scores on the aggression subscale of the LEIDS-R remained significant (; ).

3.3. Personality

The Irr+ group had significantly higher neuroticism scores (; ) and scored significantly lower on extraversion (; ), openness (; ), agreeableness (; ), and conscientiousness (; ) than the Irr- group. After correcting for age, gender, and total IDS score, the differences on neuroticism and agreeableness remained statistically significant.

3.4. Multivariate Analyses

The multivariate analyses (shown in Table 2) yielded similar results, with significant differences between Irr+ and Irr− on BAI total score (; ), LEIDS-R aggression (; ), and agreeableness (; ). Neuroticism was significant at trend level (; ).

Table 2: Demographic and clinical characteristics of low and high irritable depressed patients—multivariate resultsa.

Low irritable ()
High irritable()

Age of onset (mean ± SD)
29.0 ± 13.2
26.9 ± 12.4

Beck Anxiety Inventory (mean ± SD)
16.6 ± 9.5
23.9 ± 11.3
**

LEIDS (mean ± SD)

    Aggression
5.0 ± 4.2
8.8 ± 5.1
***

NEO FFI (mean ± SD)

    Neuroticism
41.2 ± 6.8
45.3 ± 6.1
*

    Openness
31.1 ± 5.1
30.6 ± 5.9

    Agreeableness
44.0 ± 5.0
41.4 ± 5.6
***

 *.085 < P >  .05.

**.05 < P >  .001.

*** P <  .001.

aControlled for current symptoms (IDS-total minus item 6), gender, and age.

3.4.1. Physiological Variables

Table 3 shows the outcomes on the (psycho)physiological markers. There were no significant differences in cortisol awakening response (CAR) between the Irr− and Irr+ irritable group. HDL cholesterol was significantly higher in the Irr− group (; ), but this difference was no longer significant after entering the covariates gender, age, smoking, alcohol abuse and dependence, and antidepressant and heart-medication use. Both groups did not differ significantly on measures of HRV either (all ), with and without correction for presence of cardiac disease or use of heart medication. Presence of cardiac disease (5.7% versus 6.7%) and use of heart medication (13.3% versus 16.2%) did not differ significantly between depressed patients with and without irritability.

Table 3: Psychophysiological measures.

Low irritable()
High irritable ( )

Cortisol (mean ± SD)

    aAUCi
1.9 ± 4.9
2.1 ± 5.2

    bAUCg
18.1 ± 6.2
18.2 ± 5.8

( )
()

cCholesterol (mean ± SD)

    Total cholesterol
5.2 ± 1.1
5.1 ± 1.1

    LDL cholesterol
3.2 ± 1.0
3.2 ± 1.0

    HDL cholesterol
1.6 ± 0.4
1.6 ± 0.4

()
()

dHeart rate variability (mean ± SD)

    RSArest
41.9 ± 27.7
45.6 ± 29.6

    RSAtest
40.8 ± 23.0
43.4 ± 23.9

    SDNN rest
71.2 ± 30.9
73.3 ± 31.8

    SDNNtest
62.2 ± 23.1
63.9 ± 22.9

aControlled for sex, physical activity, cardiovascular disease, time of awakening, and hours of sleep.

bControlled for smoking, physical activity, cardiovascular disease, working on testing day, and hours of daylight in month of testing.

cControlled for current symptoms (IDS-total minus item 6), sex, age, smoking, alcohol abuse and dependence, and antidepressant use.

dControlled for current symptoms (IDS-total minus item 6), sex, age, smoking, alcohol abuse and dependence, antidepressant and heart medication-use, and heart disease.

3.4.2. Irritability at One-Year Followup

Depressed patients who were irritable both at baseline and at one-year followup (Irr++) () differed from depressed patients who were nonirritable on both baseline and one-year followup (Irr−−) () on largely the same outcomes. Fewer patients in the Irr++ group were recruited from primary health care or the community (; ), and they scored higher on comorbid anxiety disorders. Their depression severity (IDS minus irritability) was also higher (; ). They scored higher on aggression reactivity (; ) and total LEIDS-R score (; ), after correction for depression severity, age, and gender. Irr++ participants also had higher neuroticism (; ) and lower agreeableness (; ) scores, after correction for age, gender, and depression severity. No physiological differences were found between the Irr++ and Irr−− groups.

4. Discussion

The present study showed that approximately half of the patients with a primary diagnosis of unipolar depression also have high levels of irritability. This is consistent with earlier research [3, 4]. Other studies have shown that the prevalence of anger attacks in patients with unipolar depression is only slightly lower at approximately 40% [6, 9, 42]. These studies, however, concerned patients recruited from secondary care facilities. In the current study, almost 60% of the patients recruited from psychiatric outpatient departments were classified as irritable. Irritability has been defined as “a feeling characterized by reduced control of temper” which often results in verbal or behavioral aggression [43]. Although irritability should be distinguished from more violent forms of aggressive and assaultive behavior, milder and more severe forms of irritability (e.g., anger attacks) may lie on a continuum [43]. Future research may investigate the exact relationship between irritability during depression and its outward manifestations such as anger attacks.

4.1. Clinical Characteristics of Irritable versus Nonirritable Depression

Irritable depressed patients were more severely depressed than nonirritable depressed patients. The difference in IDS scores was 10 points, which is more than one standard deviation. The severity of anxiety symptoms and suicidality was also higher. Moreover, irritable depressed patients were more often diagnosed with a comorbid anxiety disorder. The onset of depression was approximately two years earlier in the irritable depressed. They were also somewhat older at study entry and were more often recruited from secondary care facilities. With regards to their psychological profile, differences between irritable and nonirritable depressed patients were observed on a broad range of personality traits and cognitive vulnerability indices. However, after correction for depression severity, irritable depressed patients only had higher scores of aggression reactivity and lower scores of the personality trait agreeableness. Although participants are categorized into high- and low-irritable groups on the basis of one symptom, the psychological profile observed in the present study supports the validity of the subgroups.

4.2. Physiological Differences between Irritable and Nonirritable Depression

We found no differences between irritable and nonirritable depressed patients on any of the physiological markers that were investigated. Although HDL cholesterol was significantly higher in nonirritable patients, this result was no longer significant after correction for several covariates. No differences were observed on measures of heart rate variability (HRV) and cortisol awakening rise (CAR). We subsequently investigated the possibility that these physiological markers are related to more stringently defined subtypes, by selecting participants who were also depressed at one-year followup and showed either high or low scores of irritability at both time points. This comparison produced exactly the same pattern of findings. Irritable depressed patients had a greater prevalence of anxiety disorders and higher depression severity and aggression reactivity. Again, no differences were found on any of the physiological measures after correction for overall depression severity. The absence of differences at the physiological level was unexpected since studies in healthy samples have found greater HPA-axis reactivity [44, 45] and increased cardiac reactivity as a function of hostility and aggression [46, 47]. However, in a population-based sample anxiety and hostility were not related with HRV but with baroreflex sensitivity, which may be a more sensitive measure of vagal activity [47]. In depressed patients, the studies that investigated cardiac and HPA-axis reactivity concern comparisons between patients with and without anger attacks. These studies found higher cholesterol concentrations in depressed patients with anger attacks [48]. We found no support for this finding in the present sample of irritable versus nonirritable depressed patients.

In the present study, HRV was assessed at rest and during a task that required cognitive effort. Cortisol samples were collected at home. It has been suggested that depressed patients with anxiety-aggression behaviors also have a greater sensitivity to stress [49]. It could be that irritable depressed patients only show greater HPA-axis and cardiac reactivity when exposed to a more significant stressor than performing a cognitive test. This could be further tested using the same measures as in the present study in combination with laboratory stress or anger induction paradigms.

The clinical and psychological characteristics observed in the irritable depressed patients resemble a subtype of depression proposed by Van Praag [49–51]. He stated that aggression combined with anxiety is the primary feature of a subtype of depression which he called “stressor-precipitated, cortisol-induced, serotonin-related, anxiety/aggression-driven” (SeCA) depression [19]. This subtype may be further characterized by increased 5-HT disturbances, in which low mood is a secondary symptom [50] and with aggression disturbances as primary symptom. Unfortunately, markers of 5-HT function were not available in the present study.

4.3. Symptoms of Bipolar Disorder in Irritable versus Nonirritable Depression

We also observed differences between irritable and nonirritable depressed patients on three symptoms of hypomania as measured by the MDQ: distractibility, talkativeness, and racing thoughts. Future longitudinal analyses of NESDA participants may show whether irritability during depression is a risk factor for the development of bipolar disorder.

4.4. Strengths and Limitations of the Current Study

The current study had several strengths, including a rather large sample size of currently depressed patients. Diagnoses were determined using a standardized interview. Patients were recruited from different sites and facilities, which increases the generalizability of the findings. The cross-sectional design is a limitation. This was partially remediated by the inclusion of a one-year follow up measurement of the clinical variables, which allowed us to investigate a more stable subgroup of irritable depressed patients. Although other studies used the same method [3, 4], the fact that the distinction between irritable and nonirritable depressed was based on just one symptom can be seen as a limitation. We interpret the selective differences on cognitive reactivity and personality as supporting the validity of the distinction.

4.5. Future Directions

Our findings indicate several clinical differences between depressed patients with and without irritability. High levels of irritability during depression are associated with more severe depression, higher levels of anxiety, and more comorbid anxiety disorders. Anxiety during depression is associated with poorer outcome, including higher risk of chronic depression, poorer treatment response [52], and increased suicide incidence [53]. Moreover, we found higher levels of aggression reactivity, hopelessness, and disagreeableness in irritable depressed patients. Both hopelessness and aggression reactivity have been associated with increased suicide risk [54]. Therefore, it is important to continue the investigation into possible underlying mechanisms of this form of depression. There is evidence that depressed patients with aggression dysregulation problems have more pronounced 5-HT alterations [49, 50, 55–57]. Moreover, there is some evidence that depression in combination with aggression (hostility, anger) is partly under genetic control [58].

5. Conclusion

In this cross-sectional assessment, approximately half of depressed patients were classified as irritable. These patients differ from low-irritable depressed patients on several other aspects of the clinical presentation, including depression severity and comorbid anxiety. Personality and cognitive vulnerability measures also differ between these groups. Future longitudinal studies in depressed patients are needed to investigate the consequences of high levels of irritability in terms of risk of bipolar disorder, course of disease and treatment response.

Acknowledgments

The infrastructure for the NESDA study (http://www.nesda.nl/) is funded through the Geestkracht program of the Netherlands Organization for Health Research and Development (ZON-MW, Grant no. 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL), and Netherlands Institute of Mental Health and Addition (Trimbos). The present paper was facilitated by a Grant from the Netherlands Science Organization (N.W.O.-MaGW) to AJWVdD (Vici Grant no. 453-005-06).

References

APA, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, 4th edition, 2001.

M. Crowe, N. Ward, B. Dunnachie, and M. Roberts, “Characteristics of adolescent depression,” International Journal of Mental Health Nursing, vol. 15, no. 1, pp. 10–18, 2006.

M. Fava, I. Hwang, A. J. Rush, N. Sampson, E. E. Walters, and R. C. Kessler, “The importance of irritability as a symptom of major depressive disorder: results from the national comorbidity survey replication,” Molecular Psychiatry, vol. 15, no. 8, pp. 856–867, 2010.

R. H. Perlis, M. Fava, M. H. Trivedi et al., “Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder,” Acta Psychiatrica Scandinavica, vol. 119, no. 4, pp. 282–289, 2009.

M. Fava, K. Anderson, and J. F. Rosenbaum, “‘Anger attacks’: possible variants of panic and major depressive disorders,” The American Journal of Psychiatry, vol. 147, no. 7, pp. 867–870, 1990.

M. Fava and J. F. Rosenbaum, “Anger attacks in depression,” Depression and Anxiety, vol. 8, supplement 1, pp. 59–63, 1998.

M. Fava and J. F. Rosenbaum, “Anger attacks in patients with depression,” Journal of Clinical Psychiatry, vol. 60, supplement 15, pp. 21–24, 1999.

M. Fava, A. A. Nierenberg, F. M. Quitkin et al., “A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia,” Psychopharmacology Bulletin, vol. 33, no. 1, pp. 101–103, 1997.

M. Fava, J. F. Rosenbaum, J. A. Pava, M. K. McCarthy, R. J. Steingard, and E. Bouffides, “Anger attacks in unipolar depression, part 1: clinical correlates and response to fluoxetine treatment,” The American Journal of Psychiatry, vol. 150, no. 8, pp. 1158–1163, 1993.

R. Fraguas, D. V. Iosifescu, B. Bankier et al., “Major depressive disorder with anger attacks and cardiovascular risk factors,” International Journal of Psychiatry in Medicine, vol. 37, no. 1, pp. 99–111, 2007.

J. Tedlow, V. Leslie, B. R. Keefe et al., “Axis I and axis II disorder comorbidity in unipolar depression with anger attacks,” Journal of Affective Disorders, vol. 52, no. 1–3, pp. 217–223, 1999.

D. V. Iosifescu, P. F. Renshaw, D. D. Dougherty et al., “Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities,” Journal of Nervous and Mental Disease, vol. 195, no. 2, pp. 175–178, 2007.

J. E. Alpert, T. Petersen, P. A. Roffi et al., “Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks,” Psychotherapy and Psychosomatics, vol. 72, no. 2, pp. 102–106, 2003.

M. Fava, R. D. Vuolo, E. C. Wright, A. A. Nierenberg, J. E. Alpert, and J. F. Rosenbaum, “Fenfluramine challenge in unipolar depression with and without anger attacks,” Psychiatry Research, vol. 94, no. 1, pp. 9–18, 2000.

D. D. Dougherty, S. L. Rauch, T. Deckersbach et al., “Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks,” Archives of General Psychiatry, vol. 61, no. 8, pp. 795–804, 2004.

F. Benazzi and K. Bong Koh, “Anger in bipolar depression,” Journal of Clinical Psychiatry, vol. 64, no. 4, pp. 480–481, 2003.

F. Benazzi, “Irritability in depression can be a symptom of mixed depression,” Acta Psychiatrica Scandinavica, vol. 121, no. 1, p. 80, 2010.

F. Benazzi and H. Akiskal, “Irritable-hostile depression: further validation as a bipolar depressive mixed state,” Journal of Affective Disorders, vol. 84, no. 2-3, pp. 197–207, 2005.

H. M. van Praag, “Faulty cortisol/serotonin interplay: psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression),” Psychiatry Research, vol. 65, no. 3, pp. 143–157, 1996.

B. W. J. H. Penninx, A. T. F. Beekman, J. H. Smit et al., “The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods,” International Journal of Methods in Psychiatric Research, vol. 17, no. 3, pp. 121–140, 2008.

L. N. Robins, J. Wing, H. U. Wittchen et al., “The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures,” Archives of General Psychiatry, vol. 45, no. 12, pp. 1069–1077, 1988.

T. F. Babor, H. R. Kranzler, and R. J. Lauerman, “Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures,” Addictive Behaviors, vol. 14, no. 2, pp. 139–157, 1989.

A. J. Rush, C. M. Gullion, M. R. Basco, R. B. Jarrett, and M. H. Trivedi, “The inventory of depressive symptomatology (IDS): psychometric properties,” Psychological Medicine, vol. 26, no. 3, pp. 477–486, 1996.

A. T. Beck, N. Epstein, G. Brown, and R. A. Steer, “An inventory for measuring clinical anxiety: psychometric properties,” Journal of Consulting and Clinical Psychology, vol. 56, no. 6, pp. 893–897, 1988.

R. M. A. Hirschfeld, C. Holzer, J. R. Calabrese et al., “Validity of the mood disorder questionnaire: a general population study,” The American Journal of Psychiatry, vol. 160, no. 1, pp. 178–180, 2003.

A. T. Beck, M. Kovacs, and A. Weissman, “Assessment of suicidal intention: the scale for suicide ideation,” Journal of Consulting and Clinical Psychology, vol. 47, no. 2, pp. 343–352, 1979.

W. Van der Does, “Cognitive reactivity to sad mood: structure and validity of a new measure,” Behaviour Research and Therapy, vol. 40, no. 1, pp. 105–120, 2002.

J. M. G. Williams, A. J. W. Van der Does, T. Barnhofer, C. Crane, and Z. S. Segal, “Cognitive reactivity, suicidal ideation and future fluency: preliminary investigation of a differential activation theory of hopelessness/suicidality,” Cognitive Therapy and Research, vol. 32, no. 1, pp. 83–104, 2008.

P. T. Costa Jr. and R. R. McCrae, “Domains and facets: hierarchical personality assessment using the revised NEO personality inventory,” Journal of Personality Assessment, vol. 64, no. 1, pp. 21–50, 1995.

S. Wüst, J. Wolf, D. H. Hellhammer, I. Federenko, N. Schommer, and C. Kirschbaum, “The cortisol awakening response—normal values and confounds,” Noise and Health, vol. 2, pp. 79–88, 2000.

J. C. Pruessner, C. Kirschbaum, G. Meinlschmid, and D. H. Hellhammer, “Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change,” Psychoneuroendocrinology, vol. 28, no. 7, pp. 916–931, 2003.

S. A. Vreeburg, W. J. G. Hoogendijk, J. van Pelt et al., “Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study,” Archives of General Psychiatry, vol. 66, no. 6, pp. 617–626, 2009.

A. K. B. van Reedt Dortland, E. J. Giltay, T. van Veen, J. van Pelt, F. G. Zitman, and B. W. J. H. Penninx, “Associations between serum lipids and major depressive disorder: results from the Netherlands study of depression and anxiety (NESDA),” Journal of Clinical Psychiatry, vol. 71, no. 6, pp. 729–736, 2010.

E. J. C. de Geus, G. H. M. Willemsen, C. H. A. M. Klaver, and L. J. P. van Doornen, “Ambulatory measurement of respiratory sinus arrhythmia and respiration rate,” Biological Psychology, vol. 41, no. 3, pp. 205–227, 1995.

A. D. Goedhart, S. Van der Sluis, J. H. Houtveen, G. Willemsen, and E. J. C. de Geus, “Comparison of time and frequency domain measures of RSA in ambulatory recordings,” Psychophysiology, vol. 44, no. 2, pp. 203–215, 2007.

J. H. Houtveen, S. Rietveld, and E. J. C. de Geus, “Contribution of tonic vagal modulation of heart rate, central respiratory drive, respiratory depth, and respiratory frequency to respiratory sinus arrhythmia during mental stress and physical exercise,” Psychophysiology, vol. 39, no. 4, pp. 427–436, 2002.

C. M. M. Licht, E. J. C. de Geus, F. G. Zitman, W. J. G. Hoogendijk, R. van Dyck, and B. W. J. H. Penninx, “Association between major depressive disorder and heart rate variability in The Netherlands study of depression and anxiety (NESDA),” Archives of General Psychiatry, vol. 65, no. 12, pp. 1358–1367, 2008.

B. G. Tabachnik and L. S. Fidell, Using Multivariate Statistics, Pearson Education, 5th edition, 2007.

J. P. Stevens, Applied Multivariate Statistics for the Social Sciences, Lawrence Erlbaum Associates Publishers, London, UK, 2002.

S. A. Vreeburg, B. P. Kruijtzer, J. van Pelt et al., “Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology,” Psychoneuroendocrinology, vol. 34, no. 8, pp. 1109–1120, 2009.

M. Booth, “Assessment of physical activity: an international perspective,” Research Quarterly for Exercise and Sport, vol. 71, supplement 2, pp. S114–S120, 2000.

M. Fava, J. F. Rosenbaum, M. McCarthy, J. Pava, R. Steingard, and E. Bless, “Anger attacks in depressed outpatients and their response to fluoxetine,” Psychopharmacology Bulletin, vol. 27, no. 3, pp. 275–279, 1991.

R. P. Snaith and C. M. Taylor, “Irritability definition, assessment and associated factors,” The British Journal of Psychiatry, vol. 147, pp. 127–136, 1985.

R. Böhnke, K. Bertsch, M. R. Kruk, and E. Naumann, “The relationship between basal and acute HPA axis activity and aggressive behavior in adults,” Journal of Neural Transmission, vol. 117, no. 5, pp. 629–637, 2010.

G. Gerra, A. Zaimovic, P. Avanzini et al., “Neurotransmitter-neuroendocrine responses to experimentally induced aggression in humans: influence of personality variable,” Psychiatry Research, vol. 66, no. 1, pp. 33–43, 1997.

S. A. Neumann, S. R. Waldstein, J. J. Sollers III, J. F. Thayer, and J. D. Sorkin, “Hostility and distraction have differential influences on cardiovascular recovery from anger recall in women,” Health Psychology, vol. 23, no. 6, pp. 631–640, 2004.

R. Virtanen, A. Jula, J. K. Salminen et al., “Anxiety and hostility are associated with reduced baroreflex sensitivity and increased beat-to-beat blood pressure variability,” Psychosomatic Medicine, vol. 65, no. 5, pp. 751–756, 2003.

M. Fava, M. Abraham, J. Pava, J. Shuster, and J. Rosenbaum, “Cardiovascular risk factors in depression: the role of anxiety and anger,” Psychosomatics, vol. 37, no. 1, pp. 31–37, 1996.

H. M. van Praag, “Serotonin-related, anxiety/aggression-driven, stressor-precipitated depression: a psycho-biological hypothesis,” European Psychiatry, vol. 11, no. 2, pp. 57–67, 1996.

H. M. van Praag, “5-HT-related, anxiety- and/or aggression-driven depression,” International Clinical Psychopharmacology, vol. 9, supplement 1, pp. 5–6, 1994.

H. M. van Praag, “Anxiety/aggression—driven depression: a paradigm of functionalization and verticalization of psychiatric diagnosis,” Progress in Neuropsychopharmacology & Biological Psychiatry, vol. 25, no. 4, pp. 893–924, 2001.

C. van Valkenburg, H. S. Akiskal, V. Puzantian, and T. Rosenthal, “Anxious depressions: clinical, family history, and naturalistic outcome—comparisons with panic and major depressive disorders,” Journal of Affective Disorders, vol. 6, no. 1, pp. 67–82, 1984.

J. Fawcett and H. M. Kravitz, “Anxiety syndromes and their relationship to depressive illness,” Journal of Clinical Psychiatry, vol. 44, no. 8, part 2, pp. 8–11, 1983.

N. Antypa, A. J. W. Van der Does, and B. W. J. H. Penninx, “Cognitive reactivity: investigation of a potentially treatable marker of suicide risk in depression,” Journal of Affective Disorders, vol. 122, no. 1-2, pp. 46–52, 2010.

A. J. Cleare and A. J. Bond, “Experimental evidence that the aggressive effect of tryptophan depletion is mediated via the 5-HT(1A) receptor,” Psychopharmacology, vol. 147, no. 4, pp. 439–441, 2000.

J. J. Lopez-Ibor Jr., J. Saiz-Ruiz, and J. C. Perez de los Cobos, “Biological correlations of suicide and aggressivity in major depressions (with melancholia): 5-hydroxyindoleacetic acid and cortisol in cerebral spinal fluid, dexamethasone suppression test and therapeutic response to 5-hydroxytryptophan,” Neuropsychobiology, vol. 14, no. 2, pp. 67–74, 1985.

S. N. Young, M. aan het Rot, G. Pinard, and D. S. Moskowitz, “The effect of tryptophan on quarrelsomeness, agreeableness, and mood in everyday life,” International Congress Series, vol. 1304, pp. 133–143, 2007.

X. Gonda, K. N. Fountoulakis, G. Csukly et al., “Interaction of 5-HTTLPR genotype and unipolar major depression in the emergence of aggressive/hostile traits,” Journal of Affective Disorders, vol. 132, no. 3, pp. 432–437, 2011.